Bentham Science Logo

Current Neuropharmacology

Volume 17, 12 Issues, 2019
ISSN: 1875-6190 (Online)
ISSN: 1570-159X (Print)
This journal supports open access

Ranking and Category

  • 59th of 267 in

    Neurosciences

  • 33rd of 267 in

    Pharmacology & Pharmacy

Order Your Article Before Print

Contents

Current Neuropharmacology, Volume 13 - Number 5



The Involvement of TNF-α in Cognitive Dysfunction Associated with Major Depressive Disorder: An Opportunity for Domain Specific Treatments

, 13(5): 558 - 576

Beatrice Bortolato, Andre F. Carvalho, Joanna K. Soczynska, Giulia I. Perini and Roger S. McIntyre


DOI: 10.2174/1570159X13666150630171433



Treatment-resistant Late-life Depression: Challenges and Perspectives

, 13(5): 577 - 591

Christian Knochel, Gilberto Alves, Benedikt Friedrichs, Barbara Schneider, Anna Schmidt-Rechau, Sofia Wenzler, Angelina Schneider, David Prvulovic, Andre F. Carvalho and Viola Oertel-Knochel


DOI: 10.2174/1570159X1305151013200032



Pharmacological Approaches for Treatment-resistant Bipolar Disorder

, 13(5): 592 - 604

Shi Hui Poon, Kang Sim and Ross J. Baldessarini


DOI: 10.2174/1570159X13666150630171954



From Randomized Controlled Trials of Antidepressant Drugs to the Meta-Analytic Synthesis of Evidence: Methodological Aspects Lead to Discrepant Findings

, 13(5): 605 - 615

Konstantinos N. Fountoulakis, Roger S. McIntyre and Andre F. Carvalho


DOI: 10.2174/1570159X13666150630174343



Challenging Treatment-Resistant Major Depressive Disorder: A Roadmap for Improved Therapeutics

, 13(5): 616 - 635

Rafael T. de Sousa, Marcus V. Zanetti, Andre R. Brunoni and Rodrigo Machado-Vieira


DOI: 10.2174/1570159X13666150630173522



Beyond Monoamines-Novel Targets for Treatment-Resistant Depression: A Comprehensive Review

, 13(5): 636 - 655

Joshua D. Rosenblat, Roger S. McIntyre, Gilberto S. Alves, Konstantinos N. Fountoulakis and Andre F. Carvalho


DOI: 10.2174/1570159X13666150630175044



Future Directions for Pharmacotherapies for Treatment-resistant Bipolar Disorder

, 13(5): 656 - 662

Seetal Dodd, Brisa S. Fernandes and Olivia M. Dean


DOI: 10.2174/1570159X13666150630175841



Omega 3 Fatty Acids: Novel Neurotherapeutic Targets for Cognitive Dysfunction in Mood Disorders and Schizophrenia?

, 13(5): 663 - 680

Christian Knochel, Martin Voss, Florian Gruter, Gilberto S. Alves, Silke Matura, Beate Sepanski, Michael Stablein, Sofia Wenzler, David Prvulovic, Andre F. Carvalho and Viola Oertel-Knochel


DOI: 10.2174/1570159X13666150630173047



The Incidence of Akathisia in the Treatment of Schizophrenia with Aripiprazole, Asenapine and Lurasidone: A Meta-Analysis

, 13(5): 681 - 691

Jennifer E. Thomas, Joshua Caballero and Catherine A. Harrington


DOI: 10.2174/1570159X13666150115220221




Myalgic Encephalomyelitis: Symptoms and Biomarkers

, 13(5): 701 - 734

Leonard A. Jason, Marcie L. Zinn and Mark A. Zinn


DOI: 10.2174/1570159X13666150928105725





Editor-in-Chief

T.E. Salt
University College London
Institute of Ophthalmology
London EC1V9EL
UK

Biography View Full Editorial Board

Journal History

Current Neuropharmacology was introduced in 2003 with the assistance of Dr. T.E. Salt, who is the current Editor-in-Chief serving since 2003.
Track Your Manuscript:


Scopus CiteScore Metrics: 2.17

New eBook

Neurobiology of Mood Disorders



You can view the contents of this eBook [here] or purchase it [here].

Related Journals

Related eBooks

eBooks Catalog